Radiolife has been accepted into the Newchip Acceleration Program.

Interested in supporting Radiolife? Take a look at our crowdfunding campaign and join us in our efforts to disrupt global diagnostics.

We are “testing the waters” to gauge investor interest in an offering under Regulation Crowdfunding. No money or other consideration is being solicited. If sent, it will not be accepted. No offer to buy securities will be accepted. No part of the purchase price will be received until a Form C is filed and only through Wefunder’s platform. Any indication of interest involves no obligation or commitment of any kind.

Join our crowdfunding campaign!

We are “testing the waters” to gauge investor interest in an offering under Regulation Crowdfunding. No money or other consideration is being solicited. If sent, it will not be accepted. No offer to buy securities will be accepted. No part of the purchase price will be received until a Form C is filed and only through Wefunder’s platform. Any indication of interest involves no obligation or commitment of any kind.

Cube Scan

Cube Scan is an investigational medical device that has the potential to quickly and at a low cost detect different types of viruses.

It relies on our proprietary technology based on radio frequency combined with artificial intelligence modeling.

Cube Scan has already received regulatory approval for Covid-19 detection on nasal swabs in Chile, and we are awaiting a substantive review of our pre-EUA submission to the FDA.

The best solution for improving global pandemic readiness must be a lightweight, portable, fast, accurate, accessible, and upgradable device. Cube Scan is the only device that has this potential and checks all those boxes.

Click the link and join our crowdfunding campaign. Check it out: wefunder.com/radiolife

Radiolife in Europe!

On July 8th of 2022, Radiolife will be in Italy showcasing our product, Cube Scan.

Cube Scan is an investigational medical device that has the potential to quickly and at a low cost detect different types of viruses.

It relies on our proprietary technology based on radio frequency and artificial intelligence.

Cube Scan has the potential to accurately detect several diseases in a few seconds.

It has already received regulatory approval for Covid-19 detection on nasal swabs in Chile, and we are awaiting a substantive review of our pre-EUA submission to the FDA.

Come visit Radiolife in Europe and learn more about our technology.
www.maridelsud.info

To learn more about Radiolife, make sure to visit our Blog!